Login / Signup
Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan.
Lin-Chien Wang
Chun-Nan Kuo
Yu Ko
Published in:
The breast journal (2020)
Keyphrases
</>
metastatic breast cancer
epidermal growth factor receptor
positive breast cancer
glycemic control
type diabetes
metabolic syndrome
adipose tissue
breast cancer risk
tyrosine kinase